Find your next paid study

Stanford UniversityNCT06646627

~$150 – $3,000

Actual pay is set by the research site.

AnxietyDepression - Major Depressive DisorderBurnout+4 more

A Pilot Intervention to Reduce Burnout and Enhance Resilience Through Transcendental Meditation Among NewYork-Presbyterian Hospital and Weill Cornell Medicine Employees and Residents

The goal of this study is to learn if a meditation intervention called Transcendental Meditation or TM can be used in a small department at Weill Cornell Medic…

Weill Medical College of Cornell UniversityNCT07868783

Actual pay is set by the research site.

Prophylactic Conjoint Tendon Lengthening During Reverse Shoulder Arthroplasty: is There a Difference in Anterior Shoulder Pain At One Year After Surgery?

Some patients may experience persistent pain in the front of their shoulder after reverse shoulder replacement. One of the possible reasons for this is that th…

Osteoarthritis Shoulder

Nickolas GarbisNCT06729983

~$10 – $1,125

Actual pay is set by the research site.

Targeting Hypervigilance and Autonomic Arousal: the Psycho-physiologic Model of GERD

GERD affects roughly 20% of the U.S. population and the direct and indirect costs of GERD are substantial, totaling close to 50 billion dollars per year. Evide…

Gastroesophageal Reflux

Northwestern UniversityNCT04960566

Actual pay is set by the research site.

Phase 2

Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation in Non-Malignant Diseases

Alemtuzumab is an antibody that reduces the strength of the immune system that is given in preparation for allogeneic hematopoietic cell transplant (HCT). In t…

Allogeneic Hematopoietic Cell Transplantation

Children's Hospital Medical Center, CincinnatiNCT05501756

~$75 – $1,800

Actual pay is set by the research site.

Phase 1

A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

This phase 1 trial tests safety, side effects, and best dose of AOH1996 for the treatment of patients with acute myeloid leukemia (AML) that has come back afte…

Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia

City of Hope Medical CenterNCT06763341

~$150 – $3,000

Actual pay is set by the research site.

Phase 1

Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer

Background: Endometrial cancer (EC) of the uterus is becoming more common in the US. Sometimes EC often has increased levels of a protein called HER2. Cancers…

Endometrial CancerCancer of EndometriumCarcinoma of Endometrium+1 more

National Cancer Institute (NCI)NCT06253494

~$150 – $2,700

Actual pay is set by the research site.

AcceptabilityFeasibility Studies

Digital Implementation Support Strategies for Caregiver Home Practice

This project is a pilot trial of the Engaging Families home practice smartphone application (or "app") as an add on to a family-based prevention program. Altho…

Arizona State UniversityNCT06907966

Actual pay is set by the research site.

Phase 2

A Phase II Prospective 2-Arm Cohort Interventional Trial Utilizing Ultra-Hypofractionated SBRT With or Without Short Course Androgen Deprivation Therapy For Unfavorable Intermediate Risk Prostate Cancer

For this study, unfavorable intermediate risk prostate cancer patients will select whether they are to be treated with the standard of care (SOC) 6 months of A…

Prostate Cancer

NYU Langone HealthNCT06397703

~$75 – $3,000

Actual pay is set by the research site.

Osteoporosis, Postmenopausal

Mechanisms of Anabolic Osteoporosis Therapy

The aim of this study is to investigate the effect of romosozumab on bone cells during early and late phases of treatment.

Massachusetts General HospitalNCT05688969

Actual pay is set by the research site.

ESCAPE - Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

This study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (…

Prostate Cancer

Weill Medical College of Cornell UniversityNCT05948657

Actual pay is set by the research site.

Phase 1

(2R,6R)-Hydroxynorketamine a Novel Therapeutic Analgesic for the Treatment of Neuropathic Pain: A Randomized Double Blind Cross-Over Trial.

The goal of this randomized double blind three way (1:1:1) cross over clinical trial is to evaluate the effectiveness and duration of analgesia of a single inf…

Pain, Neuropathic